AU Stock MarketDetailed Quotes
HLS Healius Ltd
- 1.745
- -0.050-2.79%
20min DelayMarket Closed Oct 3 16:00 AET
1.27BMarket Cap-1782P/E (Static)
1.797High1.725Low1.04MVolume1.790Open1.795Pre Close1.81MTurnover2.30052wk High0.16%Turnover Ratio726.13MShares1.08052wk Low-0.979EPS TTM1.13BFloat Cap8.770Historical HighLossP/E (Static)650.19MShs Float0.611Historical Low-0.979EPS LYR4.01%Amplitude--Dividend TTM1.22P/B1Lot Size--Div YieldTTM
About Healius Ltd Company
Healius is Australia’s second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.
Company Profile
SymbolHLS
Company NameHealius Ltd
Founded1994
MarketASX
Employees10610
Fiscal Year Ends06-30
Address161 Castlereagh Street Level 22
CitySydney
CountryAustralia
Zip Code2000
Phone+61 294329400
Websitehttps://www.healius.com.au
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
6 Hope Street, ERMINGTON, NSW, AUSTRALIA, 2115
02 8234 5000
Company Executives
- Name
- Position
- Salary
- Paul R. Anderson
- Director, Managing Director and Chief Executive Officer
- --
- Kate Mckenzie, B.A.,L.L.B.,M.A.I.C.D.
- Non-Executive Chairman of the Board
- --
- Charlie Taylor
- Director
- --
- Dr. Michael Stanford
- Director
- --
- Professor John Mattick, A.O.
- Independent Director
- --
- Sally Evans
- Independent Director
- --
- Gordon Davis, M.B.A.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data